The aim of the study is to study the utility of various inflammatory markers in predicting outcomes of hospitalized patients with coronavirus disease 2019 (COVID-19) pneumonia.

Matéria original

Anterior

In-silico strategies to combat COVID-19: A comprehensive review

Próxima

Metoprolol in Critically Ill Patients With COVID-19